Taiyeb M. Khumri

Advanced Heart Failure and Transplant Cardiology | Cardiology
100 Ne Saint Lukes Blvd
Lees Summit, MO 64086

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications

Two Year Results of PROACTIVE-HF Trial Stratified by LVEF.

Two Year Results of PROACTIVE-HF Trial Stratified by LVEF.

Journal: Journal of cardiac failure
Published: September 25, 2025

Temporal trends, cardiovascular complications, and outcomes in patients receiving CAR T-cell therapy: a 6-year nationwide analysis.

Temporal trends, cardiovascular complications, and outcomes in patients receiving CAR T-cell therapy: a 6-year nationwide analysis.

Journal: Cardio-oncology (London, England)
Published: August 30, 2025

Comparative Outcomes of Transferred vs Nontransferred Cardiogenic Shock Patients Receiving Impella Support.

Comparative Outcomes of Transferred vs Nontransferred Cardiogenic Shock Patients Receiving Impella Support.

Journal: JACC. Advances
Published: August 20, 2025

Orthostatic Pulse Pressure as a Potential Indicator of Preload Insufficiency in HFpEF: Insights From PRESERVED-HF.

Orthostatic Pulse Pressure as a Potential Indicator of Preload Insufficiency in HFpEF: Insights From PRESERVED-HF.

Journal: JACC. Heart failure
Published: April 08, 2025

Engaging Patients and Clinicians With Remote Pulmonary Artery Pressures Monitoring Improves Care: The PROACTIVE-HF Clinical Trial.

Engaging Patients and Clinicians With Remote Pulmonary Artery Pressures Monitoring Improves Care: The PROACTIVE-HF Clinical Trial.

Journal: JACC. Heart failure
Published: October 17, 2024

Seated Pulmonary Artery Pressure Management in Patients With Heart Failure: 12-Month Outcomes of the PROACTIVE-HF Trial.

Seated Pulmonary Artery Pressure Management in Patients With Heart Failure: 12-Month Outcomes of the PROACTIVE-HF Trial.

Journal: JACC. Heart failure
Published: October 14, 2024

Seated Pulmonary Artery Pressure Monitoring in Patients With Heart Failure: Results of the PROACTIVE-HF Trial.

Seated Pulmonary Artery Pressure Monitoring in Patients With Heart Failure: Results of the PROACTIVE-HF Trial.

Journal: JACC. Heart failure
Published: April 05, 2024

Effect of Dapagliflozin on 6-Minute Walk Distance in Heart Failure With Preserved Ejection Fraction: PRESERVED-HF.

Effect of Dapagliflozin on 6-Minute Walk Distance in Heart Failure With Preserved Ejection Fraction: PRESERVED-HF.

Journal: Circulation. Heart failure
Published: October 23, 2023

Stabilization of Rapidly Progressive Cardiac Allograft Vasculopathy Using mTOR Inhibition After Heart Transplantation.

Stabilization of Rapidly Progressive Cardiac Allograft Vasculopathy Using mTOR Inhibition After Heart Transplantation.

Journal: Journal of cardiac failure
Published: September 15, 2023

Dapagliflozin Improves Heart Failure Symptoms and Physical Limitations Across the Full Range of Ejection Fraction: Pooled Patient-Level Analysis From DEFINE-HF and PRESERVED-HF Trials.

Dapagliflozin Improves Heart Failure Symptoms and Physical Limitations Across the Full Range of Ejection Fraction: Pooled Patient-Level Analysis From DEFINE-HF and PRESERVED-HF Trials.

Journal: Circulation. Heart failure
Published: May 19, 2023

The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial.

The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial.

Journal: Nature medicine
Published: August 19, 2021

PCSK9 Inhibitors in Heart Transplant Patients: Safety, Efficacy, and Angiographic Correlates.

PCSK9 Inhibitors in Heart Transplant Patients: Safety, Efficacy, and Angiographic Correlates.

Journal: Journal of cardiac failure
Published: January 10, 2021
Showing 1-12 of 21

Last Updated: 09/26/2026